American Pain Society Accepting Applications for Clinical Centers ... MarketWatch - The Clinical Centers of Excellence in Pain Management Awards Program honors forward-thinking teams of healthcare professionals who are satisfying unmet ...

Purdue Pharma LP Announces a Global Strategic Alliance With ... MarketWatch - Infinity's FAAH inhibitor program is in lead optimization and the company expects to select a clinical candidate by early 2009. Purdue and Mundipharma will ... Infinity unveils Global Strategic Alliance With Purdue Pharma ... Infinity Announces Global Strategic Alliance With Purdue Pharma ... Infinity Pharma forms global strategic alliance with Purdue Pharma ...

Eurand Appoints Dr. Ruth Thieroff-Ekerdt as Chief Medical Officer MarketWatch - Dr. Thieroff-Ekerdt will have full responsibility for managing Eurand's clinical research and development, medical and regulatory affairs, and drug safety ...

SuperGen gets FDA approval for clinical trial Bizjournals.com, NC - SuperGen Inc. has received clearance from the Food and Drug Administration to begin clinical trials of an anticancer compound, triggering a $5.2 million ...

Gloucester Pharmaceuticals to Present Positive Results from ... MarketWatch - Over 750 patients, to date, have received romidepsin in clinical trials with the most common adverse effects including fatigue, gastrointestinal ...

Cook Medical Receives Conditional Approval from FDA to Begin ... MarketWatch - "We are thrilled to receive the green light from the FDA to move forward with a clinical trial for the Zenith Low Profile AAA Endovascular Graft," said Phil ... Cook Medical's Aortic Intervention Division Builds On Success With ...

Synta Pharmaceuticals Announces First Patient Treated in Phase 1 2 ... MarketWatch - In a double-blind, randomized, controlled Phase 2b clinical trial in 81 patients with stage IV metastatic melanoma, elesclomol in combination with ... Synta tests prostate-cancer therapy

Alnylam Presents Pre- clinical Data from TTR Amyloidosis ... MarketWatch - a leading RNAi therapeutics company, announced today that it presented new pre- clinical data from its TTR amyloidosis development program at Cambridge ... Alnylam sees results for liver disease treatment

Carlos V. Paya, MD, PhD, to Join Elan as Company President MarketWatch - Dr. Paya will be based at Elan's South San Francisco campus, with particular focus on and responsibility for leading the company's scientific, clinical and ... Elan names former Eli Lilly executive as president New Elan president to be based in So. SF Elan hires Lilly executive as company president -

Quintiles, SAS Announce Development of First-Ever Clinical Trials ... MarketWatch - The Quintiles-SAS Clinical Trials Statistical Programming Certification will certify that the successful candidate has shown that he or she has the ...